Terms: = Skin cancer AND BCL11A, BCL11A-L, 53335, ENSG00000119866, FLJ34997, CTIP1, BCL11A-S, BCL11A-XL, KIAA1809, Q9H165, EVI9, FLJ10173 AND Diagnosis
3 results:
1. Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm.
Piccin A; Morello E; Svaldi M; Haferlach T; Facchetti F; Negri G; Vecchiato C; Fisogni S; Pusceddu I; Cortelazzo S
Hematol Oncol; 2012 Dec; 30(4):210-3. PubMed ID: 22915052
[TBL] [Abstract] [Full Text] [Related]
2. Novel markers of normal and neoplastic human plasmacytoid dendritic cells.
Marafioti T; Paterson JC; Ballabio E; Reichard KK; Tedoldi S; Hollowood K; Dictor M; Hansmann ML; Pileri SA; Dyer MJ; Sozzani S; Dikic I; Shaw AS; Petrella T; Stein H; Isaacson PG; Facchetti F; Mason DY
Blood; 2008 Apr; 111(7):3778-92. PubMed ID: 18218851
[TBL] [Abstract] [Full Text] [Related]
3. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis.
van Doorn R; Dijkman R; Vermeer MH; Out-Luiting JJ; van der Raaij-Helmer EM; Willemze R; Tensen CP
Cancer Res; 2004 Aug; 64(16):5578-86. PubMed ID: 15313894
[TBL] [Abstract] [Full Text] [Related]
